Abstract

Autism in Children

Author(s): Cave Stephanie

Issue: Jan/Feb 2001 - Compounding for Pediatric Patients

Page(s): 18-19

Download in electronic PDF format for $75

Abstract

Autism incorporates most of the characteristics of a metabolic disorder. In this discussion, the author focuses on biochemical markers, causes of autism and treatments.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2001 Pg. 18-19	Autism in Children Author(s): Cave Stephanie
Nov/Dec 2005 Pg. 413-420	Unlocking Autism: Is Compounding the Key? Author(s): Vail Jane
Nov/Dec 2005 Pg. 487-488	PostScription: Compounding Pharmacies and the Successful Treatment of Autism Author(s): Neurander James A
Jul/Aug 2009 Pg. 296-299	Compounding Naltrexone for the Treatment of Autism Author(s): Wynn Tom, Brunetti Sarah
Nov/Dec 2001 Pg. 436-437	Topical Secretin for the Treatment of Autism Author(s): King Erin, Toney Steve
Sep/Oct 2006 Pg. 390	Oral Rehydration Salts (World Health Organization/United Nations Children's Fund) Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 220-225	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Sep/Oct 2018 Pg. 358-366	Current Trends and Emerging Priorities in Compounded Preparations for Children Author(s): Parrish Richard H II
Sep/Oct 2020 Pg. 367-369	Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent Author(s): Cho Sung Kyung, Ashworth Lisa Diggs, Goldman Shauna
May/Jun 2016 Pg. 247-249	Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Author(s): Nahata Milap C
May/Jun 2016 Pg. 257-261	Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Author(s): Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
Sep/Oct 2017 Pg. 364-370	Child-safety Containers/Devices and Compounding Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 20-24	Sevelamer Suspension in Children with End-Stage Renal Disease Author(s): McElhiney Linda F
Jan/Feb 2007 Pg. 5-8	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2007 Pg. 27	Case Report: Treatment of Labial Adhesions in a Child Author(s): Fields Shannon W
Jul/Aug 2008 Pg. 365-367	Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Author(s): Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jan/Feb 2001 Pg. 6-8	Pediatric Compounding: Coloring Outside the Lines Author(s): Preckshot John
Jan/Feb 2009 Pg. 6-12	Compounding for Pediatric Patients: Case Reports and Formulations Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Jan/Feb 2010 Pg. 10-13	Sleepless in America: Compounding with Melatonin Author(s): Wynn Tom, Rawlings Kate
Jan/Feb 2013 Pg. 6-8	Pediatric Health Care: An Introduction Author(s): Williams LaVonn A